Endovascular options in the treatment of delayed ischemic neurological deficits due to cerebral vasospasm.

Keyphrases

• Acute Management 33%
• Aneurysmal Subarachnoid Hemorrhage (aSAH) 33%
• Cause of Disability 33%
• Cerebral Vasospasm 100%
• Clinical Change 33%
• Delayed Cerebral Ischemia 33%
• Delayed Ischemic Neurological Deficit 100%
• Endovascular 100%
• Intra-arterial 33%
• Intra-arterial Therapy 33%
• Leading Causes of Death 33%
• Medical Care 33%
• Mental Status Change 33%
• Morbidity Rate 33%
• Mortality Rate 33%
• Neurological Deficit 33%
• Plain Balloon Angioplasty 33%
• Treatment Algorithm 33%
• Vasodilator 33%
• Vasospasm 66%

Medicine and Dentistry

• Brain Ischemia 33%
• Brain Vasospasm 100%
• Intraarterial Drug Administration 33%
• Medical Care 33%
• Mental Health 33%
• Morbidity 33%
• Mortality Rate 33%
• Percutaneous Transluminal Angioplasty 33%
• Subarachnoid Hemorrhage 33%
• Vasodilator Agent 33%
• Vasospasm 66%

Pharmacology, Toxicology and Pharmaceutical Science

• Brain Ischemia 33%
• Brain Vasospasm 100%
• Morbidity 33%
• Mortality Rate 33%
• Subarachnoid Hemorrhage 33%
• Vasodilator Agent 33%
• Vasospasm 66%